Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.

Not Applicable

• Conditions: Coronary Heart Disease; Impaired Glucose Tolerance
• Interventions: Drug: Voglibose tablets

• Registration Number: NCT00724542
• Lead Sponsor: Ministry of Science and Technology of the People´s Republic of China

Brief Summary

The purpose of this study is to determine whether therapeutic intervention on impaired glucose tolerance in patients with coronary heart disease can decrease the incidence of new onset DM.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-07
• Study First Submitted: 2008-07-25
• Study First Submitted QC: 2008-07-28
• Study First Posted: 2008-07-29
• Status Verified: 2008-08
• Last Update Submitted: 2008-08-22
• Last Update Posted: 2008-08-25
• Primary Completion: 2010-12
• Study Completion: 2010-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1600

Inclusion Criteria

• Patients with coronary heart disease
• Impaired Glucose Tolerance

Exclusion Criteria

• Age < 40yr or > 75yr
• Diabetes Mellitus
• Scr > 2.0 mg/dL（176 μmol/L）
• ALT or AST > 2.5 ULN
• Hb < 90g/L
• Heart Failure
• Infection
• Undergo other interventional clinical trial

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Drug	Voglibose tablets	Voglibose tablets with lifestyle intervention

Primary Outcome Measures

Name	Time	Method
TypeⅡDiabetes Mellitus	2 years

Secondary Outcome Measures

Name	Time	Method
Occurrence of Cardiovascular Events	2 years

Trial Locations

Locations (1)

Peking University First Hospital; 🇨🇳 Beijing, Beijing, China